Press Releases
Nov 12, 2025
Corporate and finance
Novavax to Participate in Jefferies London Healthcare Conference
Nov 6, 2025
Corporate and finance
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
Nov 4, 2025
COVID-19,Corporate and finance
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Oct 30, 2025
Corporate and finance
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
Oct 22, 2025
Corporate and finance
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
Oct 7, 2025
COVID-19,Corporate and finance
Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
Sep 30, 2025
Corporate and finance,Science & technology
Novavax Announces Progress on Sanofi Agreement
Sep 19, 2025
Statement
COVID-19,Partnerships,Science & technology
Sanofi and Novavax Statement on Nuvaxovid™ COVID-19 vaccine for ACIP
Sep 4, 2025
COVID-19,Corporate and finance
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
Sep 3, 2025
Statement
COVID-19,Science & technology
Novavax Statement on Publicly Available COVID-19 Vaccine Data
Showper page